Mold overgrowth on a dry powder inhaler during routine treatment of persistent asthma.
Marcus S
MS
Shaker
Carrie
C
Mohila
Joseph
J
Schwartzman
Deborah
D
Zuaro
D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D019819:Budesonide / Q000008:administration & dosage / Q000627:therapeutic use; D002175:Candida / Q000302:isolation & purification; D002648:Child; D002963:Cladosporium / Q000302:isolation & purification; D004866:Equipment Contamination; D005658:Fungi / Q000276:immunology / Q000472:pathogenicity; D006801:Humans; D009330:Nebulizers and Vaporizers / Q000382:microbiology*; D012307:Risk Factors
D019819:Budesonide